| Breast Cancer |
1 |
1 |
| Metastasis |
0 |
0.79 |
| Triple Negative Breast Cancer |
0 |
0.66 |
| Cancer |
0 |
0.6 |
| Distant Metastasis |
0 |
0.51 |
| Breast |
0 |
0.3 |
| Prognosis |
0 |
0.3 |
| Chemotherapy |
0 |
0.18 |
| Lymphocytes |
0 |
0.99 |
| Tumor |
0 |
0.18 |
| Adjuvant Chemotherapy |
0 |
0.17 |
| Healthcare and Medical Technology |
0 |
0.13 |
| Clinical Research |
0 |
0.12 |
| Revenue and Practice Management |
0 |
0.07 |
| Europe |
0 |
0.06 |
| Grant |
0 |
0.06 |
| Neoadjuvant Therapy |
0 |
0.06 |
| Postoperative |
0 |
0.06 |
| Salary and Compensation |
0 |
0.06 |